BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 32916872)

  • 1. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
    De Pasquale V; Pavone LM
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycans in cancer: Pathogenesis and therapeutic potential.
    Yang H; Wang L
    Adv Cancer Res; 2023; 157():251-291. PubMed ID: 36725112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.
    De Pasquale V; Quiccione MS; Tafuri S; Avallone L; Pavone LM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
    Lanzi C; Zaffaroni N; Cassinelli G
    Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan Sulfate in the Tumor Microenvironment.
    Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
    Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.
    Hull EE; Montgomery MR; Leyva KJ
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coreceptor functions of cell surface heparan sulfate proteoglycans.
    Hayashida K; Aquino RS; Park PW
    Am J Physiol Cell Physiol; 2022 May; 322(5):C896-C912. PubMed ID: 35319900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.
    Nagarajan A; Malvi P; Wajapeyee N
    Front Endocrinol (Lausanne); 2018; 9():483. PubMed ID: 30197623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion.
    Marques C; Poças J; Gomes C; Faria-Ramos I; Reis CA; Vivès RR; Magalhães A
    J Biol Chem; 2022 Nov; 298(11):102546. PubMed ID: 36181793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
    Cassinelli G; Zaffaroni N; Lanzi C
    Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate proteoglycans and heparin regulate melanoma cell functions.
    Nikitovic D; Mytilinaiou M; Berdiaki A; Karamanos NK; Tzanakakis GN
    Biochim Biophys Acta; 2014 Aug; 1840(8):2471-81. PubMed ID: 24486410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.
    Fernández-Vega I; García-Suárez O; García B; Crespo A; Astudillo A; Quirós LM
    BMC Cancer; 2015 Oct; 15():742. PubMed ID: 26482785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.
    Hammond E; Khurana A; Shridhar V; Dredge K
    Front Oncol; 2014; 4():195. PubMed ID: 25105093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
    Okolicsanyi RK; van Wijnen AJ; Cool SM; Stein GS; Griffiths LR; Haupt LM
    J Cell Biochem; 2014 May; 115(5):967-76. PubMed ID: 24357546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic targets in the brain tumor microenvironment.
    Phillips JJ
    Oncotarget; 2012 May; 3(5):568-575. PubMed ID: 22643827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma.
    Reijmers RM; Spaargaren M; Pals ST
    FEBS J; 2013 May; 280(10):2180-93. PubMed ID: 23419151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate proteoglycans (HSPGs) of the ocular lens.
    Wishart TFL; Lovicu FJ
    Prog Retin Eye Res; 2023 Mar; 93():101118. PubMed ID: 36068128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycans as multifunctional cell regulators: cell surface receptors.
    Li JP; Spillmann D
    Methods Mol Biol; 2012; 836():239-55. PubMed ID: 22252639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.